Geneva Partners, LLC Medtronic PLC Transaction History

Geneva Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$99.53 - $127.75 $3.12 Million - $4 Million	-31,301 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$122.75 - $135.17 $566,982 - $624,350	-4,619 Reduced 12.86%	31,301 $3.92 Million
Q2 2021 Aug 06, 2021	BUY	$118.19 - $131.5 $2.34 Million - $2.61 Million	19,840 Added 123.38%	35,920 $4.46 Million
Q1 2021 May 05, 2021	BUY	$111.18 - $119.74 $103,397 - $111,358	930 Added 6.14%	16,080 $1.9 Million
Q4 2020 Feb 01, 2021	BUY	$100.57 - $117.14 $1.52 Million - $1.77 Million	15,150 New	15,150 $1.78 Million
Q2 2020 Jul 20, 2020	SELL	$84.11 - $103.33 $1.78 Million - $2.19 Million	-21,210 Closed	0 $0
Q1 2020 Apr 27, 2020	SELL	$72.92 - $121.3 $623,466 - $1.04 Million	-8,550 Reduced 28.73%	21,210 $1.91 Million
Q4 2019 Feb 04, 2020	SELL	$104.49 - $114.54 $138,658 - $151,994	-1,327 Reduced 4.27%	29,760 $3.38 Million
Q3 2019 Nov 06, 2019	BUY	$98.02 - $111.18 $3.05 Million - $3.46 Million	31,087 New	31,087 $3.38 Million

2,222

1.04B

7.09M

4.39M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Partners, LLC with notifications on news.